MSM: Evidence, Doses, Side Effects, and Label Guide

MSM stands for methylsulfonylmethane. Its chemical name is dimethyl sulfone, and supplemental MSM is generally produced synthetically. It is an organosulfur compound, but the number on a Supplement Facts panel normally represents the mass of MSM itself. It is not an elemental-sulfur amount and does not carry an established Daily Value. ^{10, 11}

MSM and DMSO are chemically related but different substances. MSM is sold orally as a dietary supplement. DMSO, or dimethyl sulfoxide, is a different compound most commonly discussed as a topical product. A DMSO amount should not be counted as MSM. ¹

Calling MSM “organic sulfur” describes its chemistry in broad marketing language. It does not mean certified-organic farming, prove greater absorption, or establish that a person has a sulfur deficiency.

In a 2008 systematic review, the two eligible MSM trials reported improvements in pain outcomes but had important limitations. A later meta-analysis combining MSM and DMSO trials found that the pooled pain reduction was neither statistically nor clinically significant. NCCIH therefore concludes that too little research has been conducted to determine whether MSM is helpful for osteoarthritis. ^{1, 2, 3}

A 2023 randomized trial in 88 adults with mild knee pain reported a small difference in its primary questionnaire score after 2 g per day for 12 weeks. Three of the four authors worked in the research and development department of Chlorella Industry, and the study was industry funded. That does not invalidate the trial, but it makes independent replication and the broader evidence base important. ⁶

MSM is a single defined compound rather than a botanical extract with several standardization levels. Powder, capsule, tablet, and branded raw-material wording can affect convenience or product specifications, but the disclosed MSM amount remains the main comparison number.

MSM is often researched in gram-level daily amounts, while labels may use milligrams per capsule, tablet, scoop, or multi-capsule serving. Convert the units before comparing products, then keep the facts-panel amount tied to its own serving rather than assuming everyone will use the maximum number of suggested servings.

Front-label phrases such as “clinical strength”, “pure sulfur” or “triple action” do not replace the ingredient identity, individual amount, serving size, directions, and complete formula.

MSM commonly appears with Glucosamine, Chondroitin, Collagen, or Hyaluronic Acid. These ingredients have different identities, amounts, evidence, and safety questions. More names on the front label do not automatically create a better formula.

Small knee studies used different daily amounts for limited periods. A 2006 pilot trial used 6 g per day for 12 weeks, a 2011 trial used 3.375 g per day for 12 weeks, and the 2023 mild-knee-pain trial used 2 g per day for 12 weeks. These trials do not establish one effective amount for every product, symptom, or person. ^{4, 5, 6}

The Canadian and Norwegian conclusions use different regulatory questions and uncertainty methods. Their disagreement is exactly why a studied amount should not be presented as a universally agreed safe amount, and why a low amount should not automatically be called useless without considering the claim and evidence. ^{9, 10}

Gastrointestinal discomfort, including bloating, constipation, or indigestion, is the most consistent label-level caution. NCCIH also lists allergic reactions and skin rash. Stop using a product and seek urgent care for signs of a serious allergic reaction. ^{1, 10}

In one randomized trial, 6 g per day for 16 weeks did not produce significant differences from placebo in the measured blood counts, liver and kidney markers, blood pressure, or weight. Everyone in that trial also received naproxen, participants with complex conditions were excluded, and the study did not establish safety beyond 16 weeks. ^{8, 9}

The 2025 Health Canada monograph advises consultation before use in pregnancy or breastfeeding. Reliable evidence is also insufficient for children, and no comprehensive medicine-interaction profile has been established. People with persistent joint pain, regular medicines, pregnancy, breastfeeding, or significant health conditions should review a concentrated MSM supplement with a qualified clinician or pharmacist. ^{9, 10}

FDA’s “no questions” response to GRAS Notice 229 relates to specified uses of MSM as an ingredient in certain foods. It does not approve MSM as a treatment, prove the claims on a supplement, or establish that any supplemental dose is safe for every person. ¹²